<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oncology Product Guide &#187; chemo-resistant</title>
	<atom:link href="http://www.oncologyproductguide.com/blog/tag/chemo-resistant/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.oncologyproductguide.com/blog</link>
	<description>A comprehensive guide to oncology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 12:00:01 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>NV-128 kills chemo-resistant ovarian cancer cells</title>
		<link>http://www.oncologyproductguide.com/blog/2008/04/25/nv-128-kills-chemo-resistant-ovarian-cancer-cells/</link>
		<comments>http://www.oncologyproductguide.com/blog/2008/04/25/nv-128-kills-chemo-resistant-ovarian-cancer-cells/#comments</comments>
		<pubDate>Fri, 25 Apr 2008 15:11:13 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Ovarian Cancer]]></category>
		<category><![CDATA[Tumors]]></category>
		<category><![CDATA[chemo-resistant]]></category>
		<category><![CDATA[mitochondria]]></category>
		<category><![CDATA[mTOR]]></category>
		<category><![CDATA[Novogen]]></category>
		<category><![CDATA[NV-128]]></category>
		<category><![CDATA[tumor]]></category>

		<guid isPermaLink="false">http://www.oncologyproductguide.com/blog/2008/04/25/nv-128-kills-chemo-resistant-ovarian-cancer-cells/</guid>
		<description><![CDATA[Pre-clinical studies conducted by Yale scientists have indicated that the NV-128 compound can induce the death of chemo-resistant ovarian cancer cells by halting the activation of a protein pathway called mTOR. mTOR signals enhance tumor growth in cancerous cells and inhibition of mTOR could shut down many of these survival pathways, including proteins that protect [...]]]></description>
			<content:encoded><![CDATA[<p><img border="0" vspace="5" align="left" width="200" src="http://www.oncologyproductguide.com/blog/wp-content/uploads/2008/04/novogen-logo.gif" hspace="5" alt="Novogen Logo" height="73" />Pre-clinical studies conducted by Yale scientists have indicated that the NV-128 compound can induce the death of chemo-resistant ovarian cancer cells by halting the activation of a protein pathway called mTOR. mTOR signals enhance tumor growth in cancerous cells and inhibition of mTOR could shut down many of these survival pathways, including proteins that protect the mitochondria of cancer cells. NV-128, developed by <a href="http://www.novogen.com">Novogen Limited</a>, holds promise as a more targeted therapy for ovarian cancer because it works differently from traditional therapies that are dependent on enzymes, known as caspases, to trigger cell death.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.oncologyproductguide.com/blog/2008/04/25/nv-128-kills-chemo-resistant-ovarian-cancer-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
